Literature DB >> 10411664

Skin perfusion in patients with erythromelalgia.

R C Littleford1, F Khan, J J Belch.   

Abstract

BACKGROUND: Erythromelalgia (EM) is a chronic disorder characterized by intermittent pain, warmth and erythema of the extremities. Symptoms can be precipitated by increasing the temperature of the affected limb and can be partially relieved by direct cooling.
MATERIALS AND METHODS: Microvascular assessment was conducted under 'hot' (28 degrees C) environmental conditions in 61 EM (EMI) patients and 30 control subjects. Twenty patients with many of the symptoms of EM were enrolled as an active control group (EMII). Using laser Doppler flowmetry, basal skin erythrocyte flux (SkEF) and the hyperaemic response to local heating (44 degrees C) were measured.
RESULTS: Compared with control subjects, basal SkEF was reduced at the toe (P < 0.001), index finger (P < 0.05), dorsal and plantar aspects of the foot (P < 0.01) in both patient groups and at the medial mid-calf (P < 0.05) in EMI patients. Both EM groups also had a significantly reduced maximum SkEF at the dorsum of foot and medial mid-calf (all P < 0.001) compared with control values. In a subset of patients and control subjects, transcutaneous carbon dioxide levels were raised in EMI patients (P < 0.02) compared with levels in control subjects. Toe temperature was significantly reduced in both EM groups compared with control subjects (both P < 0. 001).
CONCLUSION: Our study indicates for the first time that there is a vasoconstrictor tendency in patients with EM, which may be related to functional or structural changes in skin microvessels. Thus, the previous hypothesis that the pathophysiology of EM relates to vasodilatation is not supported in our patients. We believe that, in EM, vasoconstriction precedes reactive hyperaemia, similar to that seen in Raynaud's phenomenon.

Entities:  

Mesh:

Year:  1999        PMID: 10411664     DOI: 10.1046/j.1365-2362.1999.00510.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

2.  The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.

Authors:  J P Drenth; W H Finley; G J Breedveld; L Testers; J J Michiels; G Guillet; A Taieb; R L Kirby; P Heutink
Journal:  Am J Hum Genet       Date:  2001-03-20       Impact factor: 11.025

3.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  Sympathetic block for treating primary erythromelalgia.

Authors:  Yoo Jin Bang; Jin Seok Yeo; Si Oh Kim; Young Hoon Park
Journal:  Korean J Pain       Date:  2010-03-10

5.  Erythromelalgia in the pediatric patient: role of computed-tomography-guided lumbar sympathetic blockade.

Authors:  Anjana Kundu; Mahmood Rafiq; Patrick S Warren; Joseph D Tobias
Journal:  J Pain Res       Date:  2016-10-18       Impact factor: 3.133

6.  Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community.

Authors:  D Friberg; T Chen; G Tarr; A van Rij
Journal:  Int J Vasc Med       Date:  2013-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.